Sean Young
Papers
1
Total Citations
42
H-Index
1
About
Sean Young is a leading figure in clinical genomics, whose work centers on the development and validation of high-throughput sequencing assays for hereditary cancer syndromes. His most influential contribution is the design and clinical validation of a second-generation sequencing assay for detecting germline mutations in *BRCA1* and *BRCA2*, a study that has earned over 40 citations and set a benchmark for diagnostic accuracy in hereditary breast and ovarian cancer. Young’s research bridges the gap between cutting-edge genomic technology and real-world clinical application, ensuring that next-generation sequencing can be reliably deployed in diagnostic laboratories. His work has directly improved the sensitivity and specificity of mutation detection, enabling earlier and more precise risk assessment for patients and their families. Beyond this landmark study, Young continues to advance the field of precision oncology, focusing on the translation of genomic discoveries into routine clinical practice. His contributions have been instrumental in shaping how hereditary cancer syndromes are diagnosed, making him a key figure in the ongoing evolution of personalized medicine.
Research Focus
Key Achievements
Top Papers
- 1